Illinois Medication Assisted Treatment (MAT) Waiver Training and Resources
What is Medication Assisted Treatment (MAT)?
Medication Assisted Treatment (MAT) is the use of FDA-approved medications, in combination with counseling and behavioral therapies, to provide a “whole patient” approach to the treatment of substance use disorders.
Who is MAT Waiver Training For?
- Nurse Practitioners
- Physician Assistants
What is the Primary Purpose of MAT Waivers?
MAT Waivers’ primary purpose is the treatment of opioid use disorders (OUD). Opioids include a class of drugs often prescribed for pain—morphine, fentanyl, oxycodone, and hydrocodone—as well as illicit drugs, such as heroin. The Federal Drug Administration (FDA) has approved three medications for the treatment of OUD: methadone, buprenorphine, and naltrexone.
MAT Waiver training will introduce to physicians, nurse practioners and physician assistants a general approach to evaluation and treatment of patients presenting with problematic opioid use. Benefits and limitations of available medications and differences between them are described. An approach to choosing first and second line treatments is also presented.
Illinois M.A.T Waiver Training Opportunities
Rush Buprenorphine Training:
Doctors Swoboda, Nikolaides, and Basch of the Substance Use Intervention Team (SUIT) and Department of Psychiatry and Behavioral Sciences are offering training in the use of buprenorphine which will allow you to understand its use and prescribe it for your patients. This four hour in person training followed by four hours of online modules will results in a Buprenorphine waiver added to your DEA license and Free Rush CME! (4 hours)
Date: Monday, February 25, 2019 from 7:45am-12pm in the Academic Armour Center Room 994A.
Signup for this training here.
Illinois Medical Society:
Establishing a Buprenorphine Practice: What you need to know (online module). This is a one hour online course that will describe how to obtain a waiver for prescription of buprenorphine to treat opioid use disorder, explain how to screen and/or refer patients for buprenorphine treatment, set up and manage relationships with other health professionals in their communities, and prepare a buprenorphine treatment team. The Illinois State Medical Society designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enroll in this training here.
Buprenorphine (Data or X) waiver training course:
In-person MAT Waiver Training Course (1st portion of half-and-half) sponsored by the American Academy of Addiction Psychiatry and hosted by the Chicago Department of Public Health and Christian Community Health Center. Continuing Education credits are available. This “half” of the training is a 4-hour live training course. After attending this training, you will need to complete the online “half” and pass the 20 question exam. Physicians, NP’s, and PA’s are eligible for buprenorphine waivers. NP/PA’s will complete an additional 16 hours online (also free) in order to apply for their waiver.
Date: Thursday February 21st, 2019 from 8:00 am- 12:00 pm
Where: Christian Community Health Center; 364 Torrence Avenue, Calumet City, IL. 60409
To register, please email: firstname.lastname@example.org
Illinois College of Emergency Physicians 2019 MAT Waiver Training:
The course will be taught with an emergency medicine-specific focus by ICEP members Henry Swoboda, MD and Stephen Holtsford, MD, FACEP. This training is for ER physicians only. Physicians sign up for and attend the 4-hour live training on March 4 at ICEP. Once completed, participants will receive the second half of the course – a 4-hour online self-study portion. At the end of the course, participants are required to pass an exam with a 75% or higher before applying for their waiver.
When: March 4th, 2019 @ 3000 Woodcreek Drive, Suite 200 in Downers Grove
Online MAT Waiver Training Opportunities
Cant make the dates? Consider this online Medically Assisted Treatment (MAT) Training Opportunity:
Under the Drug Addiction Treatment Act of 2000 (DATA 2000), physicians are required to complete an eight-hour training to qualify for a waiver to prescribe and dispense buprenorphine. The following SAMHSA-supported continuing medical education (CME) courses can help physicians qualify to prescribe buprenorphine in an office setting (courses may require registration and include fees).
Find information about the eight-hour buprenorphine waiver training courses that are required for physicians to prescribe and dispense buprenorphine here.
Nurse Practitioners and Physician Assistant MAT Training Resources can be found here.